No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
The full text of this article is not currently available.
Continual collection and re-separation of circulating tumor cells from blood using multi-stage multi-orifice flow fractionation
3. W. J. Allard, J. Matera, M. C. Miller, M. Repollet, M. C. Connelly, C. Rao, A. G. J. Tibbe, J. W. Uhr, and L. W. M. M. Terstappen, Clin. Cancer Res. 10(20), 6897–6904 (2004).
5. H. Kahn, A. Presta, L. Yang, J. Blondal, M. Trudeau, L. Lickley, C. Holloway, D. McCready, D. Maclean, and A. Marks, Breast Cancer Res. Treat. 86(3), 237–247 (2004).
7. R. T. Krivacic, A. Ladanyi, D. N. Curry, H. B. Hsieh, P. Kuhn, D. E. Bergsrud, J. F. Kepros, T. Barbera, M. Y. Ho, L. B. Chen, R. A. Lerner, and R. H. Bruce, Proc. Natl. Acad. Sci. USA 101(29), 10501–10504 (2004).
10. S. Nagrath, L. Sequist, S. Maheswaran, D. Bell, D. Irimia, L. Ulkus, M. Smith, E. Kwak, S. Digumarthy, and A. Muzikansky, Nature 450(7173), 1235–1239 (2007).
11. S. Wang, K. Liu, J. Liu, Z. T. F. Yu, X. Xu, L. Zhao, T. Lee, E. K. Lee, J. Reiss, Y. K. Lee, L. W. K. Chung, J. Huang, M. Rettig, D. Seligson, K. N. Duraiswamy, C. K. F. Shen, and H. R. Tseng, Angew. Chem. Int. Ed. 50(13), 3084–3088 (2011).
12. A. Adams, P. Okagbare, J. Feng, M. Hupert, D. Patterson, J. Gottert, R. McCarley, D. Nikitopoulos, and M. Murphy, S. Soper, J. Am. Chem. Soc. 130(27), 8633–8641 (2008).
17. V. Gupta, I. Jafferji, M. Garza, V. O. Melnikova, D. K. Hasegawa, R. Pethig, and D. W. Davis, Biomicrofluidics 6(2), 024133 (2012).
27. C. Torres, Alternative Lithography: Unleashing the Potentials of Nanotechnology (Kluwer Academic, Dordrecht, 2003).
Article metrics loading...
Circulating tumor cells (CTCs) are highly correlated with the invasive behavior of cancer; as such, the ability to isolate and quantify CTCs is of great biomedical importance. This research presents a multi-stage multi-orifice flow fractionation (MS-MOFF) device formed by combining three single-stage multi-orifice segments designed for separating breast cancer cells from blood. The structure and dimensions of the MS-MOFF were determined by hydrodynamic principles to have consistent Reynolds numbers (Re) at each multi-orifice segment. From this device, we achieved improved separation efficiency by collecting and re-separating non-selected target cells in comparison with the single-stage multi-orifice flow fractionation (SS-MOFF). The recovery of breast cancer cells increased from 88.8% to greater than 98.9% through the multi-stage multi-orifice segments. This device can be utilized to isolate rare cells from human blood, such as CTCs, in a label-free manner solely through the use of hydrodynamic forces.
Full text loading...
Most read this month